NEW YORK (GenomeWeb News) - Ingenuity Systems said today that a group of researchers studying neuropsychiatric disorders will use its pathway analysis software to track genetic links to certain diseases.
The Pritzker Neuropsychiatric Disorders Research Consortium will use the Ingenuity Pathway Analysis software in research aimed at understanding the genetic and biological causes of disorders such as depression, manic depression, bipolar disorder, and schizophrenia in order to identify targets for treatments.
The PNDRC includes researchers and groups at the University of Michigan, Weill Medical College of Cornell University, Stanford University, the University of California at Irvine, and the University of California at Davis.
The consortium will use the software to study customized pathways that can link gene expression profiles to functions, diseases, pathways and molecular mechanisms, the company said.
Financial terms of the agreement were not released.